The U.S. Supreme Court has temporarily blocked a lower court ruling that would have ended mail delivery of mifepristone, a medication used to end pregnancies and manage miscarriages. The hold gives the Court time to make a final decision by May 11. For many Houstonians, mifepristone obtained through out-of-state telehealth services is the main path to abortion care because Texas bans most abortions.
Mifepristone is an FDA (Food and Drug Administration)-approved medication that has been on the market since 2000. A 2023 FDA rule allowed doctors to prescribe it remotely and have it mailed to patients. The 5th Circuit struck down that rule, citing a lawsuit filed in Louisiana. Justice Samuel Alito issued a temporary hold on the 5th Circuit's decision, pausing it until May 11 while the full Supreme Court decides what happens next. Meanwhile, Texas has joined Florida in suing the FDA over mifepristone's original approval. Texas also passed House Bill 7, which allows lawsuits seeking up to $100,000 against doctors or companies that provide abortion-inducing drugs. However, 22 states have shield laws that protect out-of-state providers from those penalties.
Stay close to trusted local news sources as the May 11 Supreme Court deadline approaches. If you or someone you know depends on mifepristone for any reason, including pregnancy loss care, talk with a healthcare provider now about options and any changes to access. If reproductive healthcare policy matters to you, contacting your elected representatives is a direct way to make your views heard. Local reproductive health organizations can give you the most current information on what is available in Texas right now.
No fixed date
Not location-specific
This ruling connects to ongoing conversations in Houston and across Texas about reproductive healthcare, pregnancy loss care, and the role of telehealth in reaching patients in restrictive states. It also ties into broader debates about FDA authority, state abortion bans, and the legal battles between Texas Attorney General Ken Paxton and out-of-state healthcare providers.
Texas bans most abortions, so many residents rely on doctors in other states who can prescribe mifepristone by telehealth and mail it here. The 5th U.S. Circuit Court of Appeals ruled that mifepristone must be picked up in person, which would cut off that path. About 1 in 4 abortions nationwide were provided through telemedicine through 2024, according to the Society of Family Planning. Mifepristone is also commonly used alongside misoprostol to manage miscarriages and other pregnancy complications, so the ruling affects more than abortion access alone.
